Skip to content
- Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use.
- Abbotts R, Dellomo AJ, Rassool FV.
- Cancers (Basel). 2022 May 26;14(11):2640. doi: 10.3390/cancers14112640.
- Imaging PARP with [18F]rucaparib in pancreatic cancer models.
- Chan CY, Chen Z, Destro G, Veal M, Lau D, O'Neill E, Dias G, Mosley M, Kersemans V, Guibbal F, Gouverneur V, Cornelissen B.
- Eur J Nucl Med Mol Imaging. 2022 May 26. doi: 10.1007/s00259-022-05835-4. Epub ahead of print.